Original BioMedicals Co., Ltd. (TPEX:6483)
Taiwan · Delayed Price · Currency is TWD 15.05
-0.10 (-0.66%)
Apr 29, 2026, 1:57 PM CST
Original BioMedicals Revenue
In the year 2025, Original BioMedicals had annual revenue of 381.00K TWD.
Revenue
381.00K
Revenue Growth
n/a
P/S Ratio
2,639.09
Revenue / Employee
16.57K
Employees
23
Market Cap
1.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 381.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 43.00K | -64.00K | -59.81% |
| Dec 31, 2022 | 107.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Prince Pharmaceutical | 1.06B |
| Excelsior Biopharma | 898.26M |
| Anxo Pharmaceutical | 883.22M |
| DV Biomed | 794.18M |
| Winston Medical Supply | 700.07M |
| GeneFerm Biotechnology | 677.10M |
| Tien Liang BioTech | 511.79M |
| Bioray Biotech | 230.06M |